Biotechnology Information Institute

Biotechnology Information Institute

Our IP is For Sale! This includes the domain names BIOPHARMA.com, BIOPHARMA.org, AAVvectors.com and dozens of other 'BIOPHARMA(ceutical)' industry domains.

The Biotechnology Information Institute (BII) has serially developed unique high-end information resources (most archived, not currently marketed) and provides consulting serving critical needs of the biotechnology and pharmaceutical communities, particularly concerning biopharmaceuticals, their manufacturing (bioprocessing); the biopharma industry and related information resources, competitive intelligence, market research, etc. As a sole proprietorship, Ronald A. Rader, President, is responsible for all of BII's products information resources including:

BIOPHARMA: Biopharmaceutical Products in the U.S. and European Markets: Still the only substantive (database equivalent to >2000 pages) biopharmaceutical products reference, particularly covering products's biotech, regulatory and commercial (i.e., non-medical) aspects
Biosimilars/Biobetters Pipeline Directory (Biosimilarspipeline.com): Formerly the most extensive biosimilars (and biobetters, biogenerics, etc.) pipeline information resource
Antiviral Agents Bulletin: For 15 years (1987-2003) the only industry periodical specializing in antiviral drug and vaccine development (32 pages/month; over 5,500 pages; also online database)
Federal Bio-Technology Transfer Directory: Covered all federal, e.g., NIH, inventions (patents) and technology transfers (licenses) in the biotechnology/biomedical areas (687-page book in 1994; online database to 2000)

BII is currently concentrating on divesting its IP.

BIOPHARMA: Biopharmaceutical Products in the U.S. and European Markets
archived database (up to ~2012/3) now free online Emphasis on products' biotechnology and commerical aspects In-depth descriptive and analytical monographs, with in-depth indexing and relational links Recognized as the essential reference for all concerned with biopharmaceuticals - See the reviews.

Earlier works authored by R. Rader published by the Biotechnology Information Institute:

Antiviral Agents Bulletin

- from April 1988 to March 2003

For 15 years, the Antiviral Agents Bulletin was the only periodical specializing in the research, development and commercialization of antiviral and HIV therapeutics and vaccines. Over 5,500 pages, published monthly, 32 pages/issue, each year the Bulletin presented over 400 in-depth news articles plus hundreds of U.S patents and international patent disclosures and other information, with in-depth annual indexes, analyses and reviews.

Federal Bio-Technology Transfer Directory - 678-page book published in 1994; online database until early 2000. Abstracted/indexed all federal laboratory (e.g., NIH) patents/applications, licenses granted and Collaborative Research and Development Agreements (CRADAs) in the biomedical, biotechnology and pharmaceutical areas.

Consulting: BII offers consulting specializing in information retrieval and analysis, competitive intelligence, technology assessment, market research, real-world problem solving and information resources development/publishing concerning biotechnology and pharmaceutical products, research, development, technologies, patents/technology transfer, marketing and public affairs. See Mr. Rader's bio and full resume
Contact information:

Ronald A. Rader
President
Biotechnology Information Institute
Rockville, MD 20852
Phone: 301-424-0242
E-mail: biotech@bioinfo.com
Phone is the most reliable contact method.